Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells
Authors:
- B.I.S SrivastavaBSB.I.S Srivastava
- B BrouhardBBB Brouhard
- 1 November 1998
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 40 (3) , 179-185
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Macrophages, cytokines, and HIVJournal of Laboratory and Clinical Medicine, 1997
- Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expressionBiochemical Pharmacology, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte SubpopulationsEuropean Journal of Biochemistry, 1995
- 9-Tetrahydrocannabinol, Cytokines, and Immunity to Legionella pneumophilaExperimental Biology and Medicine, 1995
- Effect of the Psychoactive Metabolite of Marijuana, Δ9-Tetrahydrocannabinol (THC), on the Synthesis of Tumor Necrosis Factor by Human Large Granular LymphocytesCellular Immunology, 1994
- Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell typesLeukemia Research, 1993
- Cytokine modulation of HIV expressionSeminars in Immunology, 1993
- Cannabinoid‐receptor expression in human leukocytesEuropean Journal of Biochemistry, 1993
- Determination of Δ1‐tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography–mass spectrometryBiomedical Chromatography, 1989